{"nct_id":"NCT02318667","title":"Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).","status":"COMPLETED","status_verified_date":"2021-01","start_date":"2015-02-27","start_date_type":"ACTUAL","primary_completion_date":"2017-06-21","primary_completion_date_type":"ACTUAL","completion_date":"2017-09-05","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["MRK"]}